Drug approval highlights for 2003.

Gary Laustsen, Lynn Wimett

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

In the past 12 months, the FDA has approved important new pharmaceutical drugs and devices of particular interest to primary health care providers. The drugs include: Oxytrol (for urinary incontinence), Valtrex (for reducing the risk of heterosexual transmission of genital herpes), Femring (for vaginal delivery of hormone therapy), Uroxatral (for benign prostatic hypertrophy), Levitra (for erectile dysfunction), Flumist (for preventing influenza), Xolair (for asthma), Raptiva (for psoriasis), Cubicin (for skin infections), Crestor (for hypercholesterolemia), and Coreg (for severe heart failure).

Original languageEnglish (US)
JournalThe Nurse practitioner
Volume29
Issue number2
Publication statusPublished - 2004
Externally publishedYes

    Fingerprint

Cite this